# Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology

> **NCT05625724** · PHASE3 · RECRUITING · sponsor: **University Hospital, Toulouse** · enrollment: 1164 (estimated)

## Conditions studied

- ART
- Pre-Eclampsia

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05625724
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-02
- **Primary completion:** 2028-08
- **Final completion:** 2029-05
- **Target enrollment:** 1164 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05625724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05625724, "Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05625724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*